Evogene (EVGN) Total Non-Current Liabilities (2016 - 2025)

Evogene (EVGN) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 26.92% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2025, down 26.92% year-over-year, with the annual reading at $4.6 million for FY2025, 26.92% down from the prior year.
  • Total Non-Current Liabilities hit $4.6 million in Q4 2025 for Evogene, down from $6.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $15.7 million in Q4 2022 to a low of $4.6 million in Q4 2025.
  • Historically, Total Non-Current Liabilities has averaged $9.6 million across 5 years, with a median of $6.3 million in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 161.76% in 2022 and later tumbled 59.08% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $6.0 million in 2021, then surged by 161.76% to $15.7 million in 2022, then decreased by 1.52% to $15.5 million in 2023, then crashed by 59.08% to $6.3 million in 2024, then dropped by 26.92% to $4.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for EVGN at $4.6 million in Q4 2025, $6.3 million in Q4 2024, and $15.5 million in Q4 2023.